JJ Kiladjian, C Chomienne, P Fenaux - Leukemia, 2008 - nature.com Interferon (IFN) was the first cytokine discovered 50 years ago, with a wide
range of biological properties, including immunomodulatory, proapoptotic and
antiangiogenic activities, that rapidly raised interest in its therapeutic ... Cited by 13 - Related articles - All 4 versions
- ►hematologylibrary.org AN Schechter - Blood, 2008 - bloodjournal.hematologylibrary.org Much of our understanding of human physiology, and of many aspects of pathology,
has its antecedents in laboratory and clinical studies of hemoglobin. Over the
last century, knowledge of the genetics, functions, and diseases of the ... Cited by 9 - Related articles - All 8 versions
- ►hematologylibrary.org L Benjamin - Hematology, 2008 - asheducationbook.hematologylibrary.org People with sickle cell disease (SCD) are living longer, but their lives are
impacted even more by the unpredictable intermittent or constant pain that is
often poorly managed over a lifetime. To address this problem, an ... Cited by 1 - Related articles - All 6 versions
[CITATION] Specific therapies for sickle cell disease
SK Ballas, WFMC PhD, N Guo, L DeCastro, R … - JOURNAL OF THE NATIONAL MEDICAL …, 2009 - nmanet.org Methods In MSH there were 299 study participants: 153 were female (77, or 50.7%,
in the hydroxyurea group; 76, or 51.7%, in the placebo group) and 146 were male
(75, or 49.3%, in the hydroxyurea group; 71, or 48.3%, in the placebo ... Related articles - View as HTML
SD Candrilli, 2009 - etd.ohiolink.edu Page 1. MEDICATION ADHERENCE AND ASSOCIATED OUTCOMES IN MEDICAID ENROLLEES
WITH SICKLE CELL DISEASE DISSERTATION Presented in Partial ... Related articles - View as HTML - All 4 versions
NM Wiles, J Howard, 2009 - pubmedcentral.nih.gov Sickle cell disease (SCD) is a genetically inherited condition caused by a point
mutation in the beta globin gene. This results in the production of the abnormal
hemoglobin, sickle hemoglobin (HbS). Hydroxycarbamide, is an antimetabolite/ ... Related articles - All 3 versions
KJ Kuong, A Kuzminov - Journal of Molecular Biology, 2009 - Elsevier Hydroxyurea (HU) is a potent remedy against a variety of ailments and an
efficient inhibitor of DNA synthesis, yet its pharmacology is unclear. HU acts
in Escherichia coli by the same mechanism as it does in eukaryotes, via ... Related articles - All 2 versions
A Atashi, M SOLEYMANI, S Kaviani, A … - IRANIAN JOURNAL OF BIOTECHNOLOGY, 2008 - sid.ir Abstract Increased fetal hemoglobin (HbF) in β-globin gene dis- orders
ameliorates the clinical symptoms of the under- lying disease. 5-azacytidine,
butyrate and hydroxyurea, have been shown to activate γ-globin gene ... Related articles - View as HTML - All 2 versions
